Drumbeat for EU Approval of Leo’s Delgocitinib Cream for CHE Gets Louder
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommends the approval of Leo’s delgocitinib cream (Anzupgo) for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. The positive opinion marks the latest step toward marketing authorization in the […]